Cargando…
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence and recurrence rates, as well as the limited advances in effective disease management. Currently, a combination of cytology and cystoscopy is the routinely used methodology for diagnosis, prognosis and disease s...
Autores principales: | Lodewijk, Iris, Dueñas, Marta, Rubio, Carolina, Munera-Maravilla, Ester, Segovia, Cristina, Bernardini, Alejandra, Teijeira, Alicia, Paramio, Jesús M., Suárez-Cabrera, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163729/ https://www.ncbi.nlm.nih.gov/pubmed/30149597 http://dx.doi.org/10.3390/ijms19092514 |
Ejemplares similares
-
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019) -
CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
por: Lodewijk, Iris, et al.
Publicado: (2023) -
Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer
por: Bernardini, Alejandra, et al.
Publicado: (2022) -
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer
por: Rubio, Carolina, et al.
Publicado: (2022) -
EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)